With more than 20 years of senior management experience in the medical technology industry, Bob has a keen eye for groundbreaking medical technologies.
Bob joined Pappas in 2014 as a Senior Advisor and also currently serves as President and COO for Entellus Medical (NASDAQ:ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients. From early 2010 through the end of 2013, he was CEO of TYRX, a Pappas Ventures portfolio company that was sold to Medtronic.
Bob has over 20 years of senior management experience in the medical technology industry through numerous positions of increasing responsibility with Medtronic Inc., Instromedix-LifeWatch, ALARIS Medical Systems, Eli Lilly, and General Electric. Bob served as President of Medtronic Kyphon following the $3.9 billion acquisition of the spinal treatment business. During his time with Medtronic, Bob also served as President of Physio Control, Chief Development Officer responsible for all corporate development activities, and Vice President of U.S. Sales and Global Marketing where he was responsible for commercial operations for the Medtronic Cardiac Rhythm Management business.
Bob began his career with General Electric. In 1989 he joined Eli Lilly and through successive promotional opportunities became the International Marketing Manager for IVAC based in Europe for three years. At ALARIS Medical Systems, a $400 million infusion therapy company, his last role was as Vice President, Corporate Development. Bob then became Founder and CEO of Liquid Borders, a healthcare software development company. At Instromedix-LifeWatch, which specializes in selling non-invasive cardiac monitoring solutions, he served as President and CEO.
University of Missouri-Rolla (BS in Aerospace Engineering)
Cornell University (MBA)
© 2019 Pappas Capital, LLC. ALL RIGHTS RESERVED.